Malaria drug study in kids: no new cure, just better dosing info
NCT ID NCT05750459
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study involved 90 Ugandan children aged 6 months to 14 years with severe malaria. Researchers gave them standard IV artesunate and measured how the drug affected their body functions and cleared the parasite. The goal was to learn more about the right dose, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Makerere University-Infectious Diseases Institute
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.